CD133+ CSC-reactive CTL1 to CTL3 were established via co-culture of CD3+ T cells with three types of irradiated CD133+ CSCs derived from SF295 and U251 and one fresh human surgical glioma tissue sample, pT1, that were pretreated with or without LPS. The gene discussed is PROM1; the disease is glioma.